Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBEHAVIORAL PHARMACOLOGY

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul J. Beswick, Chas Bountra, Terry Brown, Ian B. Campbell, Iain P. Chessell, Nick Clayton, Sue D. Collins, Philip T. Davey, Helen Goodland, Norman Gray, Claudine Haslam, Jonathan P. Hatcher, A. Jacqueline Hunter, Fiona Lucas, Graham Murkitt, Alan Naylor, Elizabeth Pickup, Becky Sargent, Scott G. Summerfield, Alexander Stevens, Sharon C. Stratton and Joanne Wiseman
Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 1161-1169; DOI: https://doi.org/10.1124/jpet.104.075267
Sharon Bingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Beswick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chas Bountra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terry Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian B. Campbell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain P. Chessell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Clayton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue D. Collins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip T. Davey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Goodland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman Gray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudine Haslam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan P. Hatcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Jacqueline Hunter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Lucas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Murkitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Naylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Pickup
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Becky Sargent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott G. Summerfield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Stevens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon C. Stratton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne Wiseman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 376 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 376, Issue 2
1 Feb 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleBEHAVIORAL PHARMACOLOGY

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul J. Beswick, Chas Bountra, Terry Brown, Ian B. Campbell, Iain P. Chessell, Nick Clayton, Sue D. Collins, Philip T. Davey, Helen Goodland, Norman Gray, Claudine Haslam, Jonathan P. Hatcher, A. Jacqueline Hunter, Fiona Lucas, Graham Murkitt, Alan Naylor, Elizabeth Pickup, Becky Sargent, Scott G. Summerfield, Alexander Stevens, Sharon C. Stratton and Joanne Wiseman
Journal of Pharmacology and Experimental Therapeutics March 1, 2005, 312 (3) 1161-1169; DOI: https://doi.org/10.1124/jpet.104.075267

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleBEHAVIORAL PHARMACOLOGY

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul J. Beswick, Chas Bountra, Terry Brown, Ian B. Campbell, Iain P. Chessell, Nick Clayton, Sue D. Collins, Philip T. Davey, Helen Goodland, Norman Gray, Claudine Haslam, Jonathan P. Hatcher, A. Jacqueline Hunter, Fiona Lucas, Graham Murkitt, Alan Naylor, Elizabeth Pickup, Becky Sargent, Scott G. Summerfield, Alexander Stevens, Sharon C. Stratton and Joanne Wiseman
Journal of Pharmacology and Experimental Therapeutics March 1, 2005, 312 (3) 1161-1169; DOI: https://doi.org/10.1124/jpet.104.075267
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Varenicline and epibatidine as opioid adjuvants
  • MCAM reverses and prevents fentanyl ventilatory depression
  • Kv7 opener SCR2682 alleviates pain
Show more Behavioral Pharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics